Publications by authors named "Riad Al-Khalil"
Outcomes of 576 patients with extracorporeal life support for the treatment of perioperative cardiogenic shock.
Interdiscip Cardiovasc Thorac Surg
September 2024
Article Synopsis
- The study investigates outcomes of extracorporeal life support in patients with low-output syndrome following cardiac surgery, revealing high initial mortality rates and identifying significant risk factors for both short- and long-term survival.
- Over 570 patients were analyzed, with findings that severe aortic valve issues and previous surgeries increased in-hospital mortality, while older age and severe mitral regurgitation predicted long-term mortality, particularly for those on insulin.
- Despite poor overall outcomes, peripheral cannulation improved survival chances, and only about 32% of patients survived beyond ten years post-discharge, highlighting the need for targeted monitoring of high-risk patients.
Extracorporeal membrane oxygenation (ECMO) is increasingly used in COVID-19-related pulmonary failure and the number of patients recovering from COVID-19 is growing. Here, we assess survival and recovery 6 months after ECMO for COVID-19. From April 2020 to September 2021, n = 60 (60.
View Article and Find Full Text PDFBackground: The treatment of cardiogenic shock (CS) in peripheral hospitals may be challenging when acute mechanical circulatory support (MCS) is not available. Tertiary care centers may provide mobile extracorporeal membrane oxygenation (ECMO) teams to support the treatment of CS-patients externally.
Methods: We retrospectively analyzed our single-center experience with a mobile ECMO team focussing on decision-making and survival data of CS-patients retrieved by ECMO support from peripheral hospitals to our tertiary care center between January 2012 and October 2018.